García Rodríguez Luis Alberto, Ruigómez Ana, Panés Julián
Centro Español de Investigación Farmacoepidemiológica, Madrid, Spain.
Gastroenterology. 2006 May;130(6):1588-94. doi: 10.1053/j.gastro.2006.02.004.
BACKGROUND & AIMS: Bacterial intestinal infections have been implicated as a possible cause of exacerbation of inflammatory bowel disease (IBD). We explored the relationship between infectious gastroenteritis and the occurrence of IBD using data from the General Practice Research Database.
A cohort of patients aged 20-74 years with an episode of acute infectious gastroenteritis (n = 43,013) was identified. From the same source population, an age-, sex-, and calendar time-matched control group free of gastroenteritis was sampled (n = 50,000). Both cohorts were followed up for a mean duration of 3.5 years.
The estimated incidence rate of IBD was 68.4 per 100,000 person-years after an episode of gastroenteritis and 29.7 per 100,000 person-years in the control cohort. The hazard ratio of IBD was 2.4 (95% confidence interval [CI], 1.7-3.3) in the gastroenteritis cohort compared with the control cohort, and the excess risk was greater during the first year after the infective episode (hazard ratio, 4.1; 95% CI, 2.2-7.4). The relative risk of developing Crohn's disease in the gastroenteritis cohort was greater than that of ulcerative colitis, especially during the first year after the infective episode (hazard ratio, 6.6; 95% CI, 1.9-22.4).
Our results are compatible with the hypothesis that infectious agents causing an episode of infectious gastroenteritis could play a role in the initiation and/or exacerbation of IBD.
细菌性肠道感染被认为可能是炎症性肠病(IBD)病情加重的一个原因。我们利用全科医疗研究数据库的数据,探讨感染性肠胃炎与IBD发生之间的关系。
确定一组年龄在20 - 74岁之间、有急性感染性肠胃炎发作史的患者(n = 43,013)。从同一源人群中,抽取一个年龄、性别和日历时间匹配的无肠胃炎对照组(n = 50,000)。两个队列均随访了平均3.5年。
肠胃炎发作后IBD的估计发病率为每10万人年68.4例,对照组为每10万人年29.7例。与对照组相比,肠胃炎队列中IBD的风险比为2.4(95%置信区间[CI],1.7 - 3.3),感染发作后的第一年超额风险更大(风险比,4.1;95% CI,2.2 - 7.4)。肠胃炎队列中患克罗恩病的相对风险大于溃疡性结肠炎,尤其是在感染发作后的第一年(风险比,6.6;95% CI,1.9 - 22.4)。
我们的结果与以下假设相符,即引起感染性肠胃炎发作的病原体可能在IBD的起始和/或加重中起作用。